Trial Profile
A Phase 2 Open-Label Uncontrolled Pilot Study of KC706 in Patients With Stable, Active Pemphigus Vulgaris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Sep 2016
Price :
$35
*
At a glance
- Drugs KC 706 (Primary)
- Indications Pemphigus vulgaris
- Focus Therapeutic Use
- Sponsors Kemia
- 18 Sep 2014 New trial record